Novo Nordisk A/S (NVO)

63.52 -0.62  -0.97% NYSE Feb 20, 16:56 Delayed 2m USD

Novo Nordisk Free Cash Flow (Quarterly):

361.95M for Dec. 31, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 361.95M
Sept. 30, 2019 2.093B
June 30, 2019 1.833B
March 31, 2019 1.043B
Dec. 31, 2018 614.42M
Sept. 30, 2018 1.272B
June 30, 2018 2.084B
March 31, 2018 1.131B
Dec. 31, 2017 253.41M
Sept. 30, 2017 1.917B
June 30, 2017 1.292B
March 31, 2017 1.488B
Dec. 31, 2016 1.205B
Sept. 30, 2016 1.851B
June 30, 2016 1.959B
March 31, 2016 936.48M
Dec. 31, 2015 1.029B
Sept. 30, 2015 1.620B
June 30, 2015 1.593B
March 31, 2015 501.18M
Dec. 31, 2014 1.039B
Sept. 30, 2014 1.914B
June 30, 2014 1.330B
March 31, 2014 599.92M
Dec. 31, 2013 810.97M
   
Sept. 30, 2013 958.68M
June 30, 2013 1.109B
March 31, 2013 1.093B
Dec. 31, 2012 151.91M
Sept. 30, 2012 1.108B
June 30, 2012 1.064B
March 31, 2012 886.23M
Dec. 31, 2011 458.26M
Sept. 30, 2011 1.311B
June 30, 2011 775.20M
March 31, 2011 825.61M
Dec. 31, 2010 684.22M
Sept. 30, 2010 956.43M
June 30, 2010 536.90M
March 31, 2010 633.51M
Dec. 31, 2009 400.55M
Sept. 30, 2009 866.63M
June 30, 2009 405.26M
March 31, 2009 631.92M
Dec. 31, 2008 442.86M
Sept. 30, 2008 602.09M
June 30, 2008 531.28M
March 31, 2008 561.83M
Dec. 31, 2007 319.12M
Sept. 30, 2007 542.22M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Free Cash Flow

Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More

Advertisement

Free Cash Flow (Quarterly) Benchmarks

Benchmarks
GlaxoSmithKline PLC 3.574B
Eli Lilly and Co 1.169B
Sanofi SA --

Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum 253.41M Dec 2017
Maximum 2.093B Sep 2019
Average 1.304B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.